VistaGen Therapeutics, Inc. (VTGN) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$0.58
Day's range
$0.62

Vistagen Therapeutics Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
ORBIMED ADVISORS LLC 02/17/2026 3.06 M $2.03 M   0.00% 7.25%
TCG CROSSOVER MANAGEMENT, LLC 02/17/2026 2.68 M $1.77 M   0.00% 6.34%
VANGUARD GROUP INC 01/29/2026 1.82 M $1.21 M   8.12% 4.32%
ADAR1 CAPITAL MANAGEMENT, LLC 02/18/2026 623.58 K $412.74 K   451.53% 1.48%
STEMPOINT CAPITAL LP 02/17/2026 616.75 K $142.09 K   -75.22% 1.46%
JANE STREET GROUP, LLC 02/12/2026 527.13 K $348.91 K   74.15% 1.25%
IKARIAN CAPITAL, LLC 02/18/2026 519.08 K $343.58 K   -16.40% 1.23%
CITADEL ADVISORS LLC 02/17/2026 465.10 K $307.85 K   367.44% 1.10%
BLACKROCK, INC. 02/12/2026 422.76 K $279.82 K   -0.09% 1.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 415.40 K $274.16 K   79.59% 0.98%
CITADEL ADVISORS LLC 02/17/2026 386.60 K $255.89 K   59.36% 0.92%
GEODE CAPITAL MANAGEMENT, LLC 02/09/2026 352.84 K $233.61 K   18.29% 0.84%
LUMINUS MANAGEMENT LLC 02/17/2026 350.00 K $231.67 K   100.00% 0.83%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 334.79 K $221.60 K   291.13% 0.79%
ADVISORSHARES INVESTMENTS LLC 02/10/2026 250.19 K $165.60 K   20.86% 0.70%
MILLENNIUM MANAGEMENT LLC 02/17/2026 197.05 K $130.42 K   853.01% 0.47%
TWO SIGMA INVESTMENTS, LP 02/17/2026 195.57 K $129.45 K   -32.42% 0.46%
DIMENSIONAL FUND ADVISORS LP 02/12/2026 151.87 K $100.63 K   123.29% 0.42%
RENAISSANCE TECHNOLOGIES LLC 02/12/2026 160.79 K $106.43 K   -61.90% 0.38%
TWO SIGMA ADVISERS, LP 02/17/2026 137.73 K $91.17 K   -12.29% 0.33%
BOOTHBAY FUND MANAGEMENT, LLC 02/17/2026 134.57 K $89.07 K   -31.70% 0.32%
STATE STREET CORP 02/13/2026 121.11 K $80.17 K   25.04% 0.29%
ADAR1 CAPITAL MANAGEMENT, LLC 02/18/2026 120.00 K $79.43 K   100.00% 0.28%
DIADEMA PARTNERS LP 02/17/2026 106.50 K $70.49 K   6.29% 0.25%
GROUP ONE TRADING, L.P. 02/12/2026 106.14 K $70.25 K   266.90% 0.25%
OMERS ADMINISTRATION CORP 02/13/2026 103.40 K $68.44 K   100.00% 0.24%
DIADEMA PARTNERS LP 02/17/2026 100.00 K $66.19 K   -71.41% 0.24%
JANE STREET GROUP, LLC 02/12/2026 79.70 K $52.75 K   100.00% 0.19%
TUDOR INVESTMENT CORP ET AL 02/17/2026 76.17 K $50.42 K   100.00% 0.18%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 75.00 K $49.50 K   417.24% 0.18%
NORTHERN TRUST CORP 02/17/2026 72.66 K $48.09 K   51.07% 0.17%
04/02/2026 62.70 K $41.50 K   100.00% 0.15%
CAPTION MANAGEMENT, LLC 02/17/2026 61.40 K $40.64 K   100.00% 0.15%
QUBE RESEARCH & TECHNOLOGIES LTD 02/17/2026 60.14 K $39.81 K   100.00% 0.14%
OCCUDO QUANTITATIVE STRATEGIES LP 02/17/2026 59.04 K $39.08 K   38.25% 0.14%
UBS GROUP AG 01/29/2026 51.99 K $34.42 K   102.57% 0.12%
AMERICAN CENTURY COMPANIES INC 02/13/2026 48.77 K $32.28 K   18.74% 0.12%
ORBIMED ADVISORS LLC 02/17/2026 45.20 K $29.92 K   0.00% 0.11%
VIRTU FINANCIAL LLC 02/23/2026 37.74 K $25.00 K   100.00% 0.09%
HRT FINANCIAL LP 02/12/2026 37.59 K $24.00 K   100.00% 0.09%
ENGINEERS GATE MANAGER LP 02/17/2026 30.49 K $20.18 K   100.00% 0.07%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/13/2026 23.30 K $15.42 K   0.00% 0.07%
PERSISTENT ASSET PARTNERS LTD 02/17/2026 26.61 K $17.61 K   -64.67% 0.06%
KESTRA ADVISORY SERVICES, LLC 02/13/2026 26.03 K $17.23 K   29.95% 0.06%
HIGHTOWER ADVISORS, LLC 02/06/2026 20.63 K $13.65 K   -0.96% 0.06%
SCHONFELD STRATEGIC ADVISORS LLC 02/17/2026 21.74 K $14.39 K   99.72% 0.05%
LIGHTHOUSE INVESTMENT PARTNERS, LLC 02/17/2026 20.58 K $13.62 K   100.00% 0.05%
SHAY CAPITAL LLC 02/17/2026 20.20 K $13.37 K   100.00% 0.05%
MARSHALL WACE, LLP 02/13/2026 19.97 K $13.18 K   100.00% 0.05%
TRUVESTMENTS CAPITAL LLC 02/13/2026 16.99 K $11.25 K   96.33% 0.04%

Vistagen Therapeutics Inc. institutional Ownership - FAQ's

During the previous two years, 74 institutional investors and hedge funds held shares of Vistagen Therapeutics Inc.. The most heavily invested institutionals were:

ORBIMED ADVISORS LLC: 3.06 M

TCG Crossover Management, LLC: 2.68 M

VANGUARD GROUP INC: 1.82 M

ADAR1 Capital Management, LLC: 623,575

StemPoint Capital LP: 616,749

JANE STREET GROUP, LLC: 527,127

32.56% of Vistagen Therapeutics Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 14.22 M shares in the last 24 months. This purchase volume represents approximately $8.82 M in transactions.